The Skin We’re In

Beneath maladies of the skin lie psychosocial stigma and pain.

Written byRobert Norman
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

UNIVERSITY OF CALIFORNIA PRESS, APRIL 2014Human beings are lucky to have such an amazing natural covering—our skin. We and our largest organ constitute a partnership that thrives every day as one nourishes, protects, and even learns from the other. Yet, sometimes there is a malfunction in our skin barrier, and in the pages of my latest book, The Blue Man, I explore both the reasons for and the stories behind these unfortunate maladies. The book describes the agony of certain diseases and their attendant psychological toll; how the skin and our perception of it influence our social, cultural, spiritual, and physical being; and how we can profit from getting to know our skin better.

Each day I try to heal the pain, both physical and psychological, caused by illnesses of the skin. On many days, my primary role is that of a sympathizer, explaining to many patients that their skin diseases are not only chronic in nature but, at best, only treatable in a palliative sense. Although there may be a general perception that most skin conditions are minor or superficial, patients with protracted and severe conditions often endure serious psychosocial repercussions. Not only can these illnesses disrupt their work lives, they can also disturb many activities of daily living, including sleep, hobbies, and social contact. Using the Dermatology Life Quality Index (DLQI), the Beck Depression Inventory (BDI), and other quality of life (QOL) studies, researchers have uncovered significant ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies